Berlin’s Aiomics Secures €2 Million In Pre-Seed Round

The round was led by Vorwerk Ventures, with additional backing from Calm/Storm, Norrsken Evolve, and Rule30. A number of well-known angel investors also took part, including Konstantin Othmer, Nicolas Weber, Andrea Kranzer, and Markus Wild.

"The clinical software landscape is undergoing a fundamental transformation: artificial intelligence is driving the unbundling of existing systems. Unlike traditional software, AI can adapt much more granularly to the individual realities of different hospitals, departments, and specialties. This enables solutions like Aiomics to integrate faster and more seamlessly with enormous potential for European healthcare," said Sascha Günther, Partner at Vorwerk Ventures.

Founded in 2025 by Dr. Sven Jungmann, Dr. Nikita Tarasov, and Kirill Schitomirski, Aiomics is a German HealthTech company working with leading though not yet publicly named healthcare institutions.

Read Also - London’s CHARM Therapeutics Raises €68.5 Million Funding In Series B Round

Aiomics’ mission is to ease the pressure on healthcare systems by reducing administrative burdens and supporting the daily work of clinicians, nurses, and therapists with structured, validated, and workflow-integrated data.

The company is developing an AI-powered documentation platform designed to take over time-consuming tasks like paperwork and data entry. It captures speech, handwriting, and documents in a single streamlined workflow, checks for completeness and accuracy through a human-in-the-loop system, and then feeds structured, coded, and audit-secure data back into existing hospital systems.

This approach helps reduce errors, speeds up reimbursement processes, and allows medical staff to spend more time focused on patient care.

With the new €2 million in pre-seed funding, Aiomics plans to expand its platform, adapt it for use across different care environments from hospitals and rehab centers to telemedicine and prepare for launch in additional European markets.

Aiomics was also highlighted in EU-Startups as part of the portfolio of Norrsken Evolve, a €57 million fund focused on early-stage, impact-driven startups across Europe.

About Aiomics

Aiomics helps healthcare providers reclaim time lost to fragmented documentation. Our AI-powered co-pilot captures and validates clinical data from speech to handwriting making records complete, compliant, and instantly usable. Built for Europe’s regulatory standards, Aiomics reduces admin, prevents errors, and frees clinicians to focus on what truly matters: patient care.